Explosive growth outlook for iPhones, and mega merger in cannabis Explosive growth outlook for iPhones, and mega merger in cannabis Explosive growth outlook for iPhones, and mega merger in cannabis

Explosive growth outlook for iPhones, and mega merger in cannabis

Equities 6 minutes to read
Peter Garnry

Chief Investment Strategist

Summary:  In today's equity update we take a look at the news yesterday on explosive growth in iPhone production planned for next year sending Apple share sup 5% in yesterday's trading. However, the growth is not without risk as Apple has difficulties sourcing all the necessary components in another sign that the physical world has potentially reached a temporary limit for supporting growth without more investments and higher prices. We also take a look at the just announced merger between Aphria and Tilray creating the world's largest cannabis producer. While the metrics are the combined company and the industry are bad this merger might be what is needed to get economics of scale.

Apple shares were 5% higher yesterday pulling the equity market higher driven by a story from Nikkei News stating that the iPhone maker is planning to produce 96mn iPhones for the first half of next year significantly above the current Wall Street estimate. This production target translates into 30% growth y/y and will be a key driver behind the 15% revenue growth expected for the FY21 ending on 30 September 2021. While the news is positive for Apple has it expands and upgrade its ecosystem of iPhone users the real market value driver going forward is still the Services segment which has a higher profit margin and less capex needs. Apple is currently valued at a 3.5% free cash flow yield which is in line with other major technology companies such as Facebook and Microsoft.

Source: Saxo Group

A key risk for Apple’s ambitious production target is sourcing of key components. Competitors such as Xiaomi has also put up aggressive production targets for next year and thus everyone in the industry is scrambling to get enough components from semiconductors, memory chips and displays. This risk touches on something we have been talking about lately on our podcasts and presentations with clients. The physical world has reached a limit in its ability to service the demand that is coming through the digital world such as e-commerce, smartphones etc. The past 10 years growth in the digital world has sent signals to investors that they should invest there causing underinvestment in the physical world which is needed to support the online ecosystem. We see more and more signs that costs in the global supply chain is going up from agriculture, energy, shipping to metals. This is a theme we will be writing about tomorrow as this theme also plays into our positive view on emerging markets.

Aphria and Tilray are creating the world’s largest cannabis producer

Aphria and Tilray share are up 12% and 22% respectively in pre-market trading on news that the two cannabis producers are merging to create the world’s largest cannabis producer. The combined company would have generated $764mn in revenue, an EBITDA loss of $132mn and negative free cash flow of $502mn in the past 12 months. The raw numbers do not suggest an attractive company but rather two weak players combining with the hope of strength. This assessment might be too harsh but there is a grain of truth to this. However, on a positive not the combined company has 58% revenue growth y/y suggesting that through compounding the combined company will soon surpass $1bn in revenue and with that hopefully enough economics of scale to begin getting stable and positive operating margins. Prior to today’s market action the combined company would have an enterprise value of $4.56bn translating the equity valuation into an EV/Sales ratio of 6x which is rather high for a manufacturing type company in an industry that so far seems to be a commodity with no clear moats to protect shareholders.

Source: Saxo Group

We wrote about the cannabis industry back in February in our industry analysis Can the cannabis industry turn growth into profits?. In this piece we looked at the 22 largest public-listed companies and showed that the combined revenue at the time was $2.47bn generating a negative free cash flow of $3.15bn. These poor operating metrics had led to the leading cannabis index to be down almost 60% since September 2018. Since February not much as changed for the positive with the S&P/MX International Cannabis Index down 54% since inception and thus the industry has not experienced the same attention and speculative fever in 2020 as technology companies. Our view on the industry is still negative, but maybe 2021 is the year when economics of scale becomes evident and maybe this merger is what the industry needs.

Source: Bloomberg

Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 05

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article
  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article
  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article
  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article
  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.